Philip Marsden is a panelist during the session titled “FTC Hearings & Other Ongoing Consultations.”
For more information on this event, click here.
What’s 340B? An economist’s view of the recent wave of 340B litigation
But this change has led to complex relationships among pharmaceutical manufacturers, hospitals, pharmacies, and third-party administrators, increasing...
